Skip to main content
Erschienen in: Medical Microbiology and Immunology 3/2013

01.06.2013 | Original Investigation

Hepatitis B escape mutants in Scottish blood donors

verfasst von: Osmany Larralde, Brian Dow, Lisa Jarvis, Fiona Davidson, Juraj Petrik

Erschienen in: Medical Microbiology and Immunology | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Hepatitis B virus (HBV) remains as the viral infection with the highest risk of transmission by transfusion. This risk is associated with window period donations, occult HBV infection (OBI) and the emergence of escape mutants, which render blood donations false negative for hepatitis B surface antigen (HBsAg) serological testing. A retrospective study was conducted to gain insights into the molecular epidemiology of HBV escape mutants in Scottish blood donors. The criterion for selection was HBV positivity either by serology or nucleic acid testing (NAT). HBsAg detection was compared across several commercial immunoassays. The full length S gene from plasma samples was PCR amplified, cloned and expressed in HepG2 cells. Eight samples showed HBsAg discordant results, while 5 OBI samples were found. Four escape mutants, containing missense mutations in the S gene, are described here. These mutations impaired HBsAg detection both from HBV infected plasma samples and from recombinant proteins derived from its infected donors. Phylogenetic analysis showed that most of the mutants were clustered in the genotype D and were closely related to strains from Asia and the Middle East. We report here a proline substitution, outside the major hydrophilic region, that impaired HBsAg detection in vivo and in vitro, warning about the risk for the emergence of vaccine escape mutants with mutations outside the major neutralisation site.
Literatur
3.
Zurück zum Zitat Allain JP (2004) Occult hepatitis B virus infection: implications in transfusion. Vox Sang 86:83–91PubMedCrossRef Allain JP (2004) Occult hepatitis B virus infection: implications in transfusion. Vox Sang 86:83–91PubMedCrossRef
4.
Zurück zum Zitat Allain JP, Candotti D (2009) Diagnostic algorithm for HBV safe transfusion. Blood Transfus 7:174–182PubMed Allain JP, Candotti D (2009) Diagnostic algorithm for HBV safe transfusion. Blood Transfus 7:174–182PubMed
5.
Zurück zum Zitat Allain JP, Cox L (2011) Challenges in hepatitis B detection among blood donors. Curr Opin Hematol 18:461–466PubMedCrossRef Allain JP, Cox L (2011) Challenges in hepatitis B detection among blood donors. Curr Opin Hematol 18:461–466PubMedCrossRef
6.
Zurück zum Zitat Cleland A, Nettleton P, Jarvis L, Simmonds P (1999) Use of bovine viral diarrhoea virus as an internal control for amplification of hepatitis C virus. Vox Sang 76:170–174PubMedCrossRef Cleland A, Nettleton P, Jarvis L, Simmonds P (1999) Use of bovine viral diarrhoea virus as an internal control for amplification of hepatitis C virus. Vox Sang 76:170–174PubMedCrossRef
7.
Zurück zum Zitat Jarvis L, Becker J, Tender A, Cleland A, Queiros L, Aquiar A, Azevedo J, Aprili G, Bressan F, Torres P, Nieto S, Ursitti A, Montoro J, Vila E, Ramada C, Saldanha J (2008) Evaluation of the Roche cobas s 201 system and cobas TaqScreen multiplex test for blood screening: a European multicenter study. Transfusion 48:1853–1861PubMedCrossRef Jarvis L, Becker J, Tender A, Cleland A, Queiros L, Aquiar A, Azevedo J, Aprili G, Bressan F, Torres P, Nieto S, Ursitti A, Montoro J, Vila E, Ramada C, Saldanha J (2008) Evaluation of the Roche cobas s 201 system and cobas TaqScreen multiplex test for blood screening: a European multicenter study. Transfusion 48:1853–1861PubMedCrossRef
8.
Zurück zum Zitat Gnaneshan S, Ijaz S, Moran J, Ramsay M, Green J (2007) HepSEQ: international public health repository for hepatitis B. Nucleic Acids Res 35:D367–D370PubMedCrossRef Gnaneshan S, Ijaz S, Moran J, Ramsay M, Green J (2007) HepSEQ: international public health repository for hepatitis B. Nucleic Acids Res 35:D367–D370PubMedCrossRef
9.
Zurück zum Zitat Kay A, Zoulim F (2007) Hepatitis B virus genetic variability and evolution. Virus Res 127:164–176PubMedCrossRef Kay A, Zoulim F (2007) Hepatitis B virus genetic variability and evolution. Virus Res 127:164–176PubMedCrossRef
10.
Zurück zum Zitat Kearse M, Moir R, Wilson A, Stones-Havas S, Cheung M, Sturrock S, Buxton S, Cooper A, Markowitz S, Duran C, Thierer T, Ashton B, Meintjes P, Drummond A (2012) Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28:1647–1649PubMedCrossRef Kearse M, Moir R, Wilson A, Stones-Havas S, Cheung M, Sturrock S, Buxton S, Cooper A, Markowitz S, Duran C, Thierer T, Ashton B, Meintjes P, Drummond A (2012) Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28:1647–1649PubMedCrossRef
11.
Zurück zum Zitat Ponde RA (2011) The underlying mechanisms for the “isolated positivity for the hepatitis B surface antigen (HBsAg)” serological profile. Med Microbiol Immunol 200:13–22PubMedCrossRef Ponde RA (2011) The underlying mechanisms for the “isolated positivity for the hepatitis B surface antigen (HBsAg)” serological profile. Med Microbiol Immunol 200:13–22PubMedCrossRef
12.
Zurück zum Zitat Persson B, Argos P (1994) Prediction of transmembrane segments in proteins utilising multiple sequence alignments. J Mol Biol 237:182–192PubMedCrossRef Persson B, Argos P (1994) Prediction of transmembrane segments in proteins utilising multiple sequence alignments. J Mol Biol 237:182–192PubMedCrossRef
13.
Zurück zum Zitat Eble BE, MacRae DR, Lingappa VR, Ganem D (1987) Multiple topogenic sequences determine the transmembrane orientation of the hepatitis B surface antigen. Mol Cell Biol 7:3591–3601PubMed Eble BE, MacRae DR, Lingappa VR, Ganem D (1987) Multiple topogenic sequences determine the transmembrane orientation of the hepatitis B surface antigen. Mol Cell Biol 7:3591–3601PubMed
14.
Zurück zum Zitat Blanchet M, Sureau C (2006) Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity. J Virol 80:11935–11945PubMedCrossRef Blanchet M, Sureau C (2006) Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity. J Virol 80:11935–11945PubMedCrossRef
15.
Zurück zum Zitat Zuckerman JN, Zuckerman AJ (2003) Mutations of the surface protein of hepatitis B virus. Antiviral Res 60:75–78PubMedCrossRef Zuckerman JN, Zuckerman AJ (2003) Mutations of the surface protein of hepatitis B virus. Antiviral Res 60:75–78PubMedCrossRef
16.
Zurück zum Zitat Ma Q, Wang Y (2012) Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen. J Med Virol 84:198–206PubMedCrossRef Ma Q, Wang Y (2012) Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen. J Med Virol 84:198–206PubMedCrossRef
17.
Zurück zum Zitat Mangold CM, Streeck RE (1993) Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. J Virol 67:4588–4597PubMed Mangold CM, Streeck RE (1993) Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. J Virol 67:4588–4597PubMed
18.
Zurück zum Zitat Huang CH, Yuan Q, Chen PJ, Zhang YL, Chen CR, Zheng QB, Yeh SH, Yu H, Xue Y, Chen YX, Liu PG, Ge SX, Zhang J, Xia NS (2012) Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J Hepatol 57:720–729PubMedCrossRef Huang CH, Yuan Q, Chen PJ, Zhang YL, Chen CR, Zheng QB, Yeh SH, Yu H, Xue Y, Chen YX, Liu PG, Ge SX, Zhang J, Xia NS (2012) Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J Hepatol 57:720–729PubMedCrossRef
19.
Zurück zum Zitat Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M (2006) Characterization of HBV DNA+/HBsAg− blood donors in Poland identified by triplex NAT. Hepatology 44:1666–1674PubMedCrossRef Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M (2006) Characterization of HBV DNA+/HBsAg− blood donors in Poland identified by triplex NAT. Hepatology 44:1666–1674PubMedCrossRef
20.
Zurück zum Zitat Carman WF, Van Deursen FJ, Mimms LT, Hardie D, Coppola R, Decker R, Sanders R (1997) The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 26:1658–1666PubMedCrossRef Carman WF, Van Deursen FJ, Mimms LT, Hardie D, Coppola R, Decker R, Sanders R (1997) The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 26:1658–1666PubMedCrossRef
21.
Zurück zum Zitat Sayiner AA, Agca H, Sengonul A, Celik A, Akarsu M (2007) A new hepatitis B virus vaccine escape mutation in a renal transplant recipient. J Clin Virol 38:157–160PubMedCrossRef Sayiner AA, Agca H, Sengonul A, Celik A, Akarsu M (2007) A new hepatitis B virus vaccine escape mutation in a renal transplant recipient. J Clin Virol 38:157–160PubMedCrossRef
22.
Zurück zum Zitat Hsu HY, Chang MH, Ni YH, Chiang CL, Chen HL, Wu JF, Chen PJ (2010) No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization. J Infect Dis 201:1192–1200PubMedCrossRef Hsu HY, Chang MH, Ni YH, Chiang CL, Chen HL, Wu JF, Chen PJ (2010) No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization. J Infect Dis 201:1192–1200PubMedCrossRef
23.
Zurück zum Zitat Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289–309PubMedCrossRef Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289–309PubMedCrossRef
24.
Zurück zum Zitat Salisse J, Sureau C (2009) A function essential to viral entry underlies the hepatitis B virus “a” determinant. J Virol 83:9321–9328PubMedCrossRef Salisse J, Sureau C (2009) A function essential to viral entry underlies the hepatitis B virus “a” determinant. J Virol 83:9321–9328PubMedCrossRef
25.
Zurück zum Zitat Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC (1990) Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325–329PubMedCrossRef Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC (1990) Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325–329PubMedCrossRef
26.
Zurück zum Zitat Kalinina T, Iwanski A, Will H, Sterneck M (2003) Deficiency in virion secretion and decreased stability of the hepatitis B virus immune escape mutant G145R. Hepatology 38:1274–1281PubMedCrossRef Kalinina T, Iwanski A, Will H, Sterneck M (2003) Deficiency in virion secretion and decreased stability of the hepatitis B virus immune escape mutant G145R. Hepatology 38:1274–1281PubMedCrossRef
27.
Zurück zum Zitat Avellon A, Echevarria JM (2006) Frequency of hepatitis B virus ‘a’ determinant variants in unselected Spanish chronic carriers. J Med Virol 78:24–36PubMedCrossRef Avellon A, Echevarria JM (2006) Frequency of hepatitis B virus ‘a’ determinant variants in unselected Spanish chronic carriers. J Med Virol 78:24–36PubMedCrossRef
28.
Zurück zum Zitat Chua PK, Wang RY, Lin MH, Masuda T, Suk FM, Shih C (2005) Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus. J Virol 79:13483–13496PubMedCrossRef Chua PK, Wang RY, Lin MH, Masuda T, Suk FM, Shih C (2005) Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus. J Virol 79:13483–13496PubMedCrossRef
29.
Zurück zum Zitat Ito K, Qin Y, Guarnieri M, Garcia T, Kwei K, Mizokami M, Zhang J, Li J, Wands JR, Tong S (2010) Impairment of hepatitis B virus virion secretion by single-amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site. J Virol 84:12850–12861PubMedCrossRef Ito K, Qin Y, Guarnieri M, Garcia T, Kwei K, Mizokami M, Zhang J, Li J, Wands JR, Tong S (2010) Impairment of hepatitis B virus virion secretion by single-amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site. J Virol 84:12850–12861PubMedCrossRef
30.
Zurück zum Zitat Warner N, Locarnini S (2008) The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. Hepatology 48:88–98PubMedCrossRef Warner N, Locarnini S (2008) The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. Hepatology 48:88–98PubMedCrossRef
31.
Zurück zum Zitat Clements CJ, Coghlan B, Creati M, Locarnini S, Tedder RS, Torresi J (2010) Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization? Bull World Health Organ 88:66–73PubMedCrossRef Clements CJ, Coghlan B, Creati M, Locarnini S, Tedder RS, Torresi J (2010) Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization? Bull World Health Organ 88:66–73PubMedCrossRef
32.
Zurück zum Zitat Scheiblauer H, El-Nageh M, Diaz S, Nick S, Zeichhardt H, Grunert HP, Prince A (2010) Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes. Vox Sang 98:403–414PubMedCrossRef Scheiblauer H, El-Nageh M, Diaz S, Nick S, Zeichhardt H, Grunert HP, Prince A (2010) Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes. Vox Sang 98:403–414PubMedCrossRef
33.
Zurück zum Zitat Bar-Yishay I, Shaul Y, Shlomai A (2011) Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression. Liver Int 31:282–290PubMedCrossRef Bar-Yishay I, Shaul Y, Shlomai A (2011) Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression. Liver Int 31:282–290PubMedCrossRef
34.
Zurück zum Zitat Chandra PK, Biswas A, Datta S, Banerjee A, Panigrahi R, Chakrabarti S, De BK, Chakravarty R (2009) Subgenotypes of hepatitis B virus genotype D (D1, D2, D3 and D5) in India: differential pattern of mutations, liver injury and occult HBV infection. J Viral Hepat 16:749–756PubMedCrossRef Chandra PK, Biswas A, Datta S, Banerjee A, Panigrahi R, Chakrabarti S, De BK, Chakravarty R (2009) Subgenotypes of hepatitis B virus genotype D (D1, D2, D3 and D5) in India: differential pattern of mutations, liver injury and occult HBV infection. J Viral Hepat 16:749–756PubMedCrossRef
35.
Zurück zum Zitat Barclay ST, Cameron S, Mills PR, Priest M, Ross F, Fox R, Goulding C, Forrest EH, Morris AJ, Neilson M, Stanley AJ (2010) The changing face of hepatitis B in greater Glasgow: epidemiological trends 1993–2007. Scott Med J 55:4–7PubMedCrossRef Barclay ST, Cameron S, Mills PR, Priest M, Ross F, Fox R, Goulding C, Forrest EH, Morris AJ, Neilson M, Stanley AJ (2010) The changing face of hepatitis B in greater Glasgow: epidemiological trends 1993–2007. Scott Med J 55:4–7PubMedCrossRef
36.
Zurück zum Zitat Mackenzie AR, Molyneaux PJ, Cadwgan AM, Laing RB, Douglas JG, Smith CC (2003) Increasing incidence of acute hepatitis B virus infection referrals to the Aberdeen Infection Unit: a matter for concern. Scott Med J 48:73–75PubMed Mackenzie AR, Molyneaux PJ, Cadwgan AM, Laing RB, Douglas JG, Smith CC (2003) Increasing incidence of acute hepatitis B virus infection referrals to the Aberdeen Infection Unit: a matter for concern. Scott Med J 48:73–75PubMed
Metadaten
Titel
Hepatitis B escape mutants in Scottish blood donors
verfasst von
Osmany Larralde
Brian Dow
Lisa Jarvis
Fiona Davidson
Juraj Petrik
Publikationsdatum
01.06.2013
Verlag
Springer-Verlag
Erschienen in
Medical Microbiology and Immunology / Ausgabe 3/2013
Print ISSN: 0300-8584
Elektronische ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-012-0283-9

Weitere Artikel der Ausgabe 3/2013

Medical Microbiology and Immunology 3/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.